These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12804070)

  • 1. Are kavalactones the hepatotoxic principle of kava extracts? The pitfalls of the glutathione theory.
    Schmidt M
    J Altern Complement Med; 2003 Apr; 9(2):183-7; author reply 187-8. PubMed ID: 12804070
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis induced by Kava (Piper methysticum rhizoma).
    Stickel F; Baumüller HM; Seitz K; Vasilakis D; Seitz G; Seitz HK; Schuppan D
    J Hepatol; 2003 Jul; 39(1):62-7. PubMed ID: 12821045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kava hepatotoxicity solution: A six-point plan for new kava standardization.
    Teschke R; Sarris J; Lebot V
    Phytomedicine; 2011 Jan; 18(2-3):96-103. PubMed ID: 21112196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevant hepatotoxic effects of kava still need to be proven. A statement of the Society for Medicinal Plant Research.
    Society for Medicinal Plant Research
    Planta Med; 2003 Nov; 69(11):971-2. PubMed ID: 14735431
    [No Abstract]   [Full Text] [Related]  

  • 5. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
    Sarris J; LaPorte E; Schweitzer I
    Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review "Kava, kavapyrones and toxic liver injury" by R Teschke, Hanau Zeitschrift für Gastroenterologie 2003, 41:395-404].
    Stickel F; Seitz HK; Schuppan D
    Z Gastroenterol; 2003 Aug; 41(8):888-9. PubMed ID: 12910431
    [No Abstract]   [Full Text] [Related]  

  • 7. Kava, the anxiolytic herb: back to basics to prevent liver injury?
    Teschke R; Sarris J; Glass X; Schulze J
    Br J Clin Pharmacol; 2011 Mar; 71(3):445-8. PubMed ID: 21284704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kava-induced fulminant hepatic failure.
    Campo JV; McNabb J; Perel JM; Mazariegos GV; Hasegawa SL; Reyes J
    J Am Acad Child Adolesc Psychiatry; 2002 Jun; 41(6):631-2. PubMed ID: 12049436
    [No Abstract]   [Full Text] [Related]  

  • 9. Kava: Piper methysticum.
    Pepping J
    Am J Health Syst Pharm; 1999 May; 56(10):957-8, 960. PubMed ID: 10365719
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic potential of kava in the treatment of anxiety disorders.
    Singh YN; Singh NN
    CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kava update: a European perspective.
    Ernst E
    N Z Med J; 2004 Nov; 117(1205):U1143. PubMed ID: 15570327
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute hepatitis due to kava-kava and St John's Wort: an immune-mediated mechanism?].
    Teschke R
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1880-1; author reply 1882-3. PubMed ID: 16915552
    [No Abstract]   [Full Text] [Related]  

  • 13. A systematic review of the safety of kava extract in the treatment of anxiety.
    Stevinson C; Huntley A; Ernst E
    Drug Saf; 2002; 25(4):251-61. PubMed ID: 11994028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia.
    Russmann S; Barguil Y; Cabalion P; Kritsanida M; Duhet D; Lauterburg BH
    Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):1033-6. PubMed ID: 12923378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kava Hepatotoxicity: Are we any closer to the truth?
    Anke J; Ramzan I
    Planta Med; 2004 Mar; 70(3):193-6. PubMed ID: 15114493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?
    Teschke R; Wolff A
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):1-7. PubMed ID: 20854865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kava: herbal panacea or liver poison?
    Moulds RF; Malani J
    Med J Aust; 2003 May; 178(9):451-3. PubMed ID: 12720513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
    Anke J; Ramzan I
    J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation and the use of KAVA: Case report.
    Becker MW; Lourençone EMS; De Mello AF; Branco A; Filho EMR; Blatt CR; Mallmann CA; Schneider M; Caregnato RCA; Blatt CR
    Phytomedicine; 2019 Mar; 56():21-26. PubMed ID: 30668342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kavalactones fail to inhibit alcohol dehydrogenase in vitro.
    Anke J; Fu S; Ramzan I
    Phytomedicine; 2006 Feb; 13(3):192-5. PubMed ID: 16428028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.